Paradigm Biopharmaceuticals | PAR - Sales Revenues

Stock Price
0.29
Daily Change
-0.02 -4.92%
Monthly
-14.71%
Yearly
-42.00%
Q1 Forecast
0.30

Paradigm Biopharmaceuticals reported AUD-8K in Sales Revenues for its fiscal semester ending in June of 2025.





Sales Change Date
Avita Medical AUD 18.42M 14K Jun/2025
Medical Developments International AUD 9.53M 1.99M Jun/2025
Neuren Pharmaceuticals AUD 14.14M 179.96M Jun/2025
Pacific Edge NZD 5.94M 4.95M Dec/2025
PYC Therapeutics AUD 13.48M 786.97K Jun/2025
Telix Pharmaceuticals AUD 309.72M 109.32M Jun/2025